Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism

Chinese Journal of Physiology

Volumn 46, Issue 4, 2003, Pages 181-186

  Simsek, Gönül ^a,b   Karter, Yesari ^a   Aydin, Seval ^a   Uzun, Hafize ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Department of Internal Medicine ^*  (Turkey)

Author keywords

Bone metabolism; Bone turnover; Hyperthyroidism; Interleukin 6; Interleukin 1 ; Tumor necrosis factor

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEVOTHYROXINE; LIOTHYRONINE; PARATHYROID HORMONE; PHOSPHORUS; THYROID HORMONE DERIVATIVE; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CELL DAMAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG MECHANISM; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HYPERTHYROIDISM; LEUKOCYTE DIFFERENTIAL COUNT; LIOTHYRONINE BLOOD LEVEL; LYMPHOCYTE COUNT; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; RAT; STATISTICAL SIGNIFICANCE; THYROID FOLLICLE CELL; THYROIDITIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0344863879     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ahmad, L., Parkes, A., Lazarus, J., Bartalena, L., Martino, E., Diamond, E. and Stagnaro-Green, A. Interleukin-6 levels are not increased in women with postpartum thyroid dysfunction. Thyroid 8: 371-375, 1998.
2. Barun, D.T. Detrimental skeletal effectts of thyrotropin suppressive doses of thyroxine: fact or fantasy? J. Clin. Endocrinol. Metabolism. 78: 816-817, 1994.
3. Barnefalk, E., Ljunghall, S., Lindh, E., Bengston, O., Johansson, A. G. and Ljunggren, O. Regulation of interleukin-6 secretion from mononuclear blood cells by extracellular calcium. J. Bone. Miner. 12: 228-233, 1997.
4. 4 -binding globulin concentration. J. Endocrinol. Invest. 16: 213-218, 1993.
5. Bisbocci, D., Gallo, V., Damiano, P., Sidoli, L., Cantoni, R., Aimo, G., Priolo, G., Pagni, R. and Chiandussi, L. Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy. J. Endocrinol. Invest. 19: 511-515, 1996.
6. Buergi, U. and Larsen, P.R. Nuclear triiodothyronine binding in mononuclear leukocytes in normal subjects and obese patients before and after fasting. J. Clin. Endocrinol. Metab. 54: 1199-1205, 1982.
7. Celik, I., Akalin, S. and Erbas, T. Serum levels of interleukin-6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur. J. Endocrinol. 132: 668-672, 1995.
8. Eriksen, E.F. and Kessem, M. The cellular basis of bone remodelling. J. Med. Sci. 31: 45-57, 1992.
9. Ganong, W.F. Review of Medical Physiology. In: Circulating Body Fluids Stamford, Appleton & Lange, 1999, pp. 493-521.
10. Garnero, P., Vassy, V., Bertholin, A., Riou, J.P. and Delman, P.D. Markers of bone turnover in hyperthyroidism and the effect of treatment. J.Clin. Endocrinol. Metab. 78: 955-959, 1994.
11. Gauldie, J., Richards, C., Horbish, D., Lansdorp, P. and Baumann, H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad Sci USA, 84: 7251-7255, 1987.
12. Girasole, G., Jilka, R.L, Passeri, G., Boswell, S., Boder, G., Williams, D.C. and Manolagas, S.C. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 89: 883-891, 1992.
13. Heuer, M., Aust, G., Ode-Hakim, S. and Scherbaum, W.A. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and non-autoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid. 6: 97-106, 1996.
14. Horowitz, M.C. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260: 626-627, 1993.
15. Karaturan, N., Şimşek, G., Güner, I., Şahin, G., Oruç, T. and Hatemi, H. Hipertrioidi oluşturulmuş anestezi altindaki tavşanlarda apneik düzeyde solunum faaliyeti, hipoksi ve hiperkapniye karşi duyarliligin incelenmesi. J. Turkish. Anaest. Rean. Soc. 29: 4-9,2001.
16. Kurihara, N., Bertolini, D., Sida, T., Akiyama, Y. and Roodman, G.D. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J. Immunol. 144: 4226-4230, 1990.
17. Lakatos, P., Foldes, J., Horvath, C., Kiss, L., Tatrai, A., Takacs, I., Taijan, G. and Stern, P.H. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J. Clin. Endocrinol. Metab. 82: 78-81, 1997.
18. Langdahl, B.L., Loft, A.G.R., Eriksen, E.F., Mosekilde, L. and Charles, P. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 6: 161-168, 1996.
19. Mc Lead, K.J., Rubin, C.T., Otter, M.W. and Qin, Y.X. Skeletal cell. Stresses and bone adaptation Am. J. Med. Sci. 316: 176-183, 1998.
20. Minelli, R., Girasole, G., Pedrazzoni, M., Giuliani, N., Schianchi, C., Giuberti, T., Braverman, L.E., Salvi, M., and Roti, E. Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy. J. Investig. Med. 44: 370-374, 1996.
21. Molnar, I. and Balazs, C. High circulating IL-6 level in Graves' ophthalmopathy Autoimmunity 25: 91-96, 1997.
22. Monolagas, S.C., Jilka, R.L., Girasole, G., Passeri, G. and Bellido, T. Estrogens cytokines and the pathophysiology of osteoporosis. In: Current opinion in endocrinology and diabetes,edited by Kohler PO, Philadelphia, Current Science, 1994, pp. 275-281.
23. Mudde, A.H., Houben, A.J. and Nieuwenhuijzen Kruseman, A.C. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin.. Endocrinol (Oxf). 41: 421-424, 1994.
24. Mundy, G.R., Shapiro, J.L., Bandelin, J.G., Canalis, E.M. and Raisz, L.G. Direct stimulation of bone resorption by thyroid hormones. J. Clin. Invest. 58: 529-534, 1976.
25. Pumarino, H. and Pumarino, M.G. Cytokines, growth factors, and metabolic bone disease. Rev. Med. Chil. 124: 248-257, 1996.
26. Rizzoli, R., Poser, J. and Burgi, U. Nuclear thyroid hormone receptors in cultured bone cells. Metabolism. 35: 71-74, 1986.
27. Schaffer, R.B. and Gregory, D.H. Calcium malabsorption in hyperthyroidism. Gastroenterology 63: 235, 1972.
28. Siddiqi, A., Burrin, J.M., Wood, D.F. and Monson, J.P. Triiodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J. Endocrinol. 157: 453-461, 1998.
29. Siddiqi, A., Monson, J.P., Wood, D.F., Besser, G.M. and Burrin, J.M. Serum cytokines in thyrotoxicosis. J. Clin. Endocrinol. Metab. 84: 435-439, 1999.
30. Simsek, G., Andican, G., Unal, E., Hatemi, H., Yigit, G. and Candan, G. Calcium, magnesium, and zinc status in experimental hyperthyroidism. Biol. Trace. Elem. Res. 57: 131-137, 1997.
31. Simsek, G., Aydin, S., Uzun, H., Karter, Y., Yigit, G., Dondurmaci, S. and Hatemi, H. The role of cytokines in bone metabolism of rats with induced hyperthyroidism. Med. Sci. Res. 25: 421-423, 1997.
32. Simsek, G., Andican, G., Karakoç, Y., Yigit, G., Hatemi, H. and Candan, G. Calcium, magnesium and zinc status in experimental hypothyroidism. Biol. Trace. Element. Res. 60: 205-213, 1997.
33. Tarjan, G. and Stern, P.H. Triiodothyronine potentiates the stimulatory effects of interleukin-1 beta on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures. J. Bone Miner. Res. 10: 1321-1326, 1995.
34. Toh, SH., Claunch, B.C. and Brown, P.H. Effect of hyperthyroidism and its treatment on bone mineral content. Arch. Intern. Med. 145: 883-886, 1985.
35. Toktamiş, N., Seven, A., Hacibekiroǧlu, M., Yiǧit, G., Candan, G., Hatemi, S. and Hatemi H. Fe parameters and euthrocytic parameters in experimental hyperthyroidism. Biochem. Soc. Trans. 21: 223S, 1993.
36. Watson, P.F., Pickerill, A.P., Davies, R. and Weetman, A.P. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J. Clin. Endocrinol. Metab. 79: 355-360, 1994.